Aquestive Therapeutics (AQST)
(Delayed Data from NSDQ)
$3.07 USD
-0.08 (-2.54%)
Updated May 23, 2024 04:00 PM ET
After-Market: $3.06 -0.01 (-0.33%) 5:52 PM ET
2-Buy of 5 2
D Value F Growth F Momentum F VGM
Brokerage Reports
Aquestive Therapeutics, Inc. [AQST]
Reports for Purchase
Showing records 341 - 360 ( 398 total )
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
2Q19 Financial Results Reported; Guidance Raised; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Q2; Positive Topline Poises Libervant For Regulatory Progress; SYMPAZAN Sales
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Long-Awaited Debt Refinancing Complete; Reduced Financial Burden; Reiterate Buy; Raising Target to $12
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Surveying the Parkinson''s Disease Treatment Continuum: KOL Conference Call Recap
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Multiple Recent Milestones Accrued; Selling Appears Overdone; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Libervant Crossover Enrolled; Topline Release On-Track for Q3
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L